These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 29449544)
1. PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d. Huang L; Wen C; Yang X; Lou Q; Wang X; Che J; Chen J; Yang Z; Wu X; Huang M; Lan P; Wang L; Iwamoto A; Wang J; Liu H Cell Death Dis; 2018 Feb; 9(3):271. PubMed ID: 29449544 [TBL] [Abstract][Full Text] [Related]
2. The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer. Ding C; Tang W; Wu H; Fan X; Luo J; Feng J; Wen K; Wu G Cancer Lett; 2019 Feb; 442():383-395. PubMed ID: 30472186 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2. Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
5. miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer. Guo X; Zhu Y; Hong X; Zhang M; Qiu X; Wang Z; Qi Z; Hong X Cell Death Dis; 2017 Jul; 8(7):e2958. PubMed ID: 28749470 [TBL] [Abstract][Full Text] [Related]
6. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway. Niu Y; Zhang J; Tong Y; Li J; Liu B Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling. Fan X; Liu M; Tang H; Leng D; Hu S; Lu R; Wan W; Yuan S J Surg Res; 2019 Aug; 240():48-59. PubMed ID: 30909065 [TBL] [Abstract][Full Text] [Related]
8. KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling. Du F; Cao T; Xie H; Li T; Sun L; Liu H; Guo H; Wang X; Liu Q; Kim T; Franklin JL; Graves-Deal R; Han W; Tian Z; Ge M; Nie Y; Fan D; Coffey RJ; Lu Y; Zhao X Theranostics; 2020; 10(16):7335-7350. PubMed ID: 32641995 [No Abstract] [Full Text] [Related]
9. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. Li X; Wang J; Zhang C; Lin C; Zhang J; Zhang W; Zhang W; Lu Y; Zheng L; Li X J Pathol; 2018 Oct; 246(2):166-179. PubMed ID: 29943828 [TBL] [Abstract][Full Text] [Related]
11. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate. Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1. Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer. Xi ZW; Xin SY; Zhou LQ; Yuan HX; Wang Q; Chen KX World J Gastroenterol; 2015 May; 21(18):5454-64. PubMed ID: 25987767 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression. Chen M; Lin M; Wang X Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158 [TBL] [Abstract][Full Text] [Related]
16. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42. Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer. Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811 [TBL] [Abstract][Full Text] [Related]
18. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway. Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746 [TBL] [Abstract][Full Text] [Related]
19. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR. Qu X; Yang L; Shi Q; Wang X; Wang D; Wu G Pathol Res Pract; 2018 Dec; 214(12):1974-1979. PubMed ID: 30262429 [TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]